Ultragenyx Pharma(RARE.US)

Last Updated 19:00:00 ET
longbridge loading

Ultragenyx Shareholders Approve Incentive Plan, Elect Directors

Tip Ranks·
US
RARE
+2.72%
Tip Ranks·
US
RARE
+2.72%

HC Wainwright Brokers Decrease Earnings Estimates for RARE

Market Beat·
US
RARE
+2.72%
US
IBBQ
+1.62%
US
PBE
0.00%
Market Beat·
US
RARE
+2.72%
US
IBBQ
+1.62%
US
PBE
0.00%

Ultragenyx Pharmaceutical (RARE) Gets a Buy from Piper Sandler

Tip Ranks·
US
RARE
+2.72%
US
IXJ
+0.75%
US
ARKG
+1.46%
Tip Ranks·
US
RARE
+2.72%
US
IXJ
+0.75%
US
ARKG
+1.46%

Universal Beteiligungs und Servicegesellschaft mbH Has $323,000 Position in Ultragenyx Pharmaceutical Inc. $RARE

Market Beat·
US
RARE
+2.72%
US
IBBQ
+1.62%
US
XBI
+1.81%
Market Beat·
US
RARE
+2.72%
US
IBBQ
+1.62%
US
XBI
+1.81%

Ultragenyx Pharmaceutical Q1 2026 Earnings Call Transcript

benzinga_article·
US
RARE
+2.72%
US
FBT
+0.76%
US
PBE
0.00%
benzinga_article·
US
RARE
+2.72%
US
FBT
+0.76%
US
PBE
0.00%

Ultragenyx Pharma | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 136 M

Earnings Watch·
US
RARE
+2.72%
Earnings Watch·
US
RARE
+2.72%

Ultragenyx CFO’s Latest Stock Move Has Investors Buzzing

Tip Ranks·
US
RARE
+2.72%
Tip Ranks·
US
RARE
+2.72%

Ultragenyx Pharmaceutical (NASDAQ:RARE) Upgraded to Hold at Wall Street Zen

Market Beat·
US
RARE
+2.72%
US
IXJ
+0.75%
US
IHE
+0.77%
Market Beat·
US
RARE
+2.72%
US
IXJ
+0.75%
US
IHE
+0.77%
© 2026 Longbridge｜Disclaimer